Related content

Is Nonalcoholic Fatty Liver Disease Indeed the Hepatic Manifestation of Metabolic Syndrome?

By  

Current Vascular Pharmacology, Vol. 16, Iss. 3, 2018-03 ,pp. : 219-227

Bentham Science Publishers

Access to resources Recommend Favorite

Insulin-related biomarkers and their relationship with hepatic fibrosis risk in patients with psoriasis, metabolic syndrome and non-alcoholic fatty liver disease

By Kawada Tomoyuki  

Journal of Gastroenterology, Vol. 48, Iss. 5, 2013-05 ,pp. : 671-672

Springer Publishing Company

Access to resources Recommend Favorite

Endocrine factors associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome: Do androgens play a role?

By Kauffman Robert P.   Baker Teresa E.   Baker Vicki   Kauffman Michele M.   Castracane V. Daniel  

Gynecological Endocrinology, Vol. 26, Iss. 1, 2010-01 ,pp. : 39-46

Informa Healthcare

Access to resources Recommend Favorite

Increased androgen bioavailability is associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome

By Vassilatou E.   Lafoyianni S.   Vryonidou A.   Ioannidis D.   Kosma L.   Katsoulis K.   Papavassiliou E.   Tzavara I.  

Human Reproduction, Vol. 25, Iss. 1, 2010-01 ,pp. : 212-220

Oxford University Press

Access to resources Recommend Favorite

High prevalence of metabolic complications in patients with non-alcoholic fatty liver disease

By Friis-Liby I.   Aldenborg F.   Jerlstad P.   Rundström K.   Björnsson E.  

Scandinavian Journal of Gastroenterology, Vol. 39, Iss. 9, 2004-09 ,pp. : 864-869

Informa Healthcare

Access to resources Recommend Favorite